FB2026_03 , released September 17, 2026
Human Disease Model Report: retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
Open Close
General Information
Name
retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
FlyBase ID
FBhh0001584
Disease Ontology Term
Parent Disease
Overview

This report describes retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations, a small-vessel disease that affects highly vascularized tissues including the retina, brain, liver, and kidneys. The human gene implicated is TREX1, Three Prime Repair Exonuclease 1. There is one high-scoring fly ortholog, Dmel\CG3165, for which multiple genetic reagents, classical alleles, RNAi-targeting constructs, and alleles caused by insertional mutagenesis have been generated.

Multiple UAS constructs of the human Hsap\TREX1 gene, including wild-type and variants implicated in human disease, have been introduced into flies. See the 'Disease-Implicated Variants' table below.

Eye-specific expression of wild-type Hsap\TREX1 results in a rough-eye phenotype. This phenotype is more pronounced when C-terminally truncated or enzymatically inactive Hsap\TREX1 is driven in the developing eye. Mutant isoforms of Hsap\TREX1 exhibit a different subcellular localization than wild-type Hsap\TREX1; while wild-type protein is predominantly cytoplasmically localized, the truncated and enzymatically inactive proteins are localized throughout the cell, including a much larger fraction in the cell nucleus.

[updated June 2024 by FlyBase; FBrf0222196]

Disease Summary Information
Disease Summary: retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
OMIM report

[VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS; RVCLS](https://omim.org/entry/192315)

Human gene(s) implicated

[3-PRIME REPAIR EXONUCLEASE 1; TREX1](https://omim.org/entry/606609)

Symptoms and phenotype

Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCLS) is an adult-onset autosomal dominant disorder involving the microvessels of the brain and resulting in central nervous system degeneration with progressive loss of vision, stroke, motor impairment, and cognitive decline. Death occurs in most patients 5 to 10 years after onset. A subset of affected individuals have systemic vascular involvement evidenced by Raynaud phenomenon, micronodular cirrhosis, and glomerular dysfunction (summary by Richards et al., 2007, pubmed:17660820). [from MIM:192315; 2024.06.12]

Genetics

Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCLS) is caused by heterozygous mutation in the TREX1 gene on chromosome 3p21. [from MIM:192315; 2024.06.12]

Cellular phenotype and pathology
Molecular information

TREX1 encodes Three Prime Repair Exonuclease 1, a nuclear protein with 3' exonuclease activity. The encoded protein may play a role in DNA repair and serve as a proofreading function for DNA polymerase. Mutations in this gene result in Aicardi-Goutieres syndrome, chilblain lupus, Cree encephalitis, and other diseases of the immune system. [provided by RefSeq, Sep 2012]

External links
Disease synonyms
cerebroretinal vasculopathry, hereditary
cerebroretinal vasculopathy
cerebroretinal vasculopathy, hereditary
CRV
hereditary cerebroretinal vasculopathy
hereditary endotheliopathy, retinopathy, nephropathy, and stroke
hereditary systemic angiopathy
hereditary vascular retinopathy
HERNS
HSA
HVR
retinal vasculopathy, cerebral leukoencephalopathy, systemic manifestations
retinal vasculopathy and cerebral leukoencephalopathy
retinal vasculopathy cerebral leukoencephalopathy
retinal vasculopathy with cerebral leukodystrophy
retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomena
retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomenon
RVCL
RVCL-S
RVCLS
vasculopathy, retinal, with cerebral leukodystrophy
vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Two to one (2 human to 1 Drosophila); GRM1 has one high-scoring Drosophila ortholog, CG3165.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Cellular component (GO)
    Gene Groups / Pathways
    Comments on ortholog(s)

    High-scoring ortholog of human TREX1, TREX2 (1 Drosophila to 2 human).

    Orthologs and Alignments from DRSC
    DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (3 groups)
      protein-protein
      Interacting group
      Assay
      References
      experimental knowledge based
      experimental knowledge based
      experimental knowledge based
      Alleles Reported to Model Human Disease (Disease Ontology) (3 alleles)
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      References (5)